Aprea Therapeutics, Inc.
APRE- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001781983
No open-market purchases or sales by Aprea Therapeutics, Inc. insiders were filed in the last 90 days; 27 institutions reported holding it in 13F filings for Q2 2026, worth $1.90M in total; no superinvestor holds it.
13F holders, Q4 2022
Institutional positions in Aprea Therapeutics, Inc. as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 25
- −2 vs. Q3 2022
- Shares held
- 1.59M
- −114.4K (−6.7%) vs. Q3 2022
- Total value
- $521.3K
- −$589.1K (−53.1%) vs. Q3 2022
- New holders
- 3
- 7 more added
- Sold out
- 5
- 7 more reduced
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting APRE on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 27 | $1.90M |
| Q1 2026 | 22 | $1.71M |
| Q4 2025 | 22 | $1.45M |
| Q3 2025 | 23 | $2.39M |
| Q2 2025 | 23 | $3.07M |
| Q1 2025 | 26 | $3.78M |
| Q4 2024 | 26 | $6.83M |
| Q3 2024 | 22 | $5.50M |
| Q2 2024 | 28 | $8.48M |
| Q1 2024 | 24 | $10.8M |
| Q4 2023 | 20 | $4.36M |
| Q3 2023 | 21 | $3.66M |
| Q2 2023 | 19 | $2.78M |
| Q1 2023 | 18 | $3.77M |
| Q4 2022 | 25 | $521.3K |
| Q3 2022 | 27 | $1.11M |
| Q2 2022 | 34 | $1.52M |
| Q1 2022 | 40 | $4.50M |
| Q4 2021 | 41 | $10.4M |
| Q3 2021 | 39 | $25.6M |
| Q2 2021 | 50 | $31.9M |
| Q1 2021 | 67 | $45.4M |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding Aprea Therapeutics, Inc.; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 310,029 | $102.6K | 0.00% | +431+0.1% | Added |
| Morgan Stanley | 275,860 | $91.3K | 0.00% | −36,156−11.6% | Reduced |
| BlackRock Inc. | 185,371 | $61.4K | 0.00% | −370−0.2% | Reduced |
| Renaissance Technologies LLC | 179,200 | $59.0K | 0.00% | −103,341−36.6% | Reduced |
| Millennium Management LLC | 164,626 | $53.0K | 0.00% | +43,293+35.7% | Added |
| Geode Capital Management, LLC | 149,711 | $48.0K | 0.00% | −431−0.3% | Reduced |
| Jane Street Group, LLC | 50,950 | $16.9K | 0.00% | +50,950 | New |
| Tower Research Capital LLC (TRC) | 47,588 | $15.0K | 0.00% | +25,270+113.2% | Added |
| Group One Trading, L.P. | 44,003 | $14.2K | 0.00% | +13,000+41.9% | Added |
| State Street Corp | 40,832 | $13.1K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 28,710 | $9.50K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 25,739 | $8.49K | 0.00% | +19,797+333.2% | Added |
| The PNC Financial Services Group, Inc. | 20,000 | $6.62K | 0.00% | 00.0% | Unchanged |
| Blackstone Group Inc. | 16,590 | $5.49K | 0.00% | 00.0% | Unchanged |
| Sugarloaf Wealth Management, LLC | 15,000 | $4.96K | 0.00% | +10,000+200.0% | Added |
| Susquehanna International Group, LLP | 13,365 | $4.30K | 0.00% | −4,297−24.3% | Reduced |
| Stifel Financial Corp | 10,000 | $3.31K | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 5,278 | $1.75K | 0.00% | +5,138+3,670.0% | Added |
| Advisor Group Holdings, Inc. | 5,050 | $1.00K | 0.00% | −6,578−56.6% | Reduced |
| Federated Hermes, Inc. | 2,253 | $746 | 0.00% | −1,212−35.0% | Reduced |
| Citadel Advisors LLC | 1,276 | $411 | 0.00% | +1,276 | New |
| Kistler-Tiffany Companies, LLC | 500 | $166 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 118 | $40 | 0.00% | +118 | New |
| Quent Capital, LLC | 75 | $25 | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 4 | $0 | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 0 | $0 | 0.00% | −61,847−100.0% | Sold out |
| Bridgeway Capital Management, LLC | 0 | $0 | 0.00% | −20,000−100.0% | Sold out |
| Verition Fund Management LLC | 0 | $0 | 0.00% | −20,101−100.0% | Sold out |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −16,843−100.0% | Sold out |
| StoneX Group Inc. | 0 | $0 | 0.00% | −12,519−100.0% | Sold out |